BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28282051)

  • 21. Chiral metallocycles: rational synthesis and novel applications.
    Lee SJ; Lin W
    Acc Chem Res; 2008 Apr; 41(4):521-37. PubMed ID: 18271561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystalline Olefin-Linked Chiral Covalent Organic Frameworks as a Platform for Asymmetric Catalysis.
    He T; On IKW; Bi S; Huang Z; Guo J; Wang Z; Zhao Y
    Angew Chem Int Ed Engl; 2024 Jul; 63(28):e202405769. PubMed ID: 38656752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetric autocatalysis of pyrimidyl alkanol and its application to the study on the origin of homochirality.
    Soai K; Kawasaki T; Matsumoto A
    Acc Chem Res; 2014 Dec; 47(12):3643-54. PubMed ID: 25511374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformationally flexible chiral supramolecular catalysts for enantioselective Diels-Alder reactions with anomalous endo/exo selectivities.
    Hatano M; Ishihara K
    Chem Commun (Camb); 2012 May; 48(36):4273-83. PubMed ID: 22441383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantioselective catalysis of photochemical reactions.
    Brimioulle R; Lenhart D; Maturi MM; Bach T
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3872-90. PubMed ID: 25728854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chiral diphosphine and monodentate phosphorus ligands on a spiro scaffold for transition-metal-catalyzed asymmetric reactions.
    Xie JH; Zhou QL
    Acc Chem Res; 2008 May; 41(5):581-93. PubMed ID: 18311931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric Catalysis in Chiral Solvents: Chirality Transfer with Amplification of Homochirality through a Helical Macromolecular Scaffold.
    Nagata Y; Takeda R; Suginome M
    ACS Cent Sci; 2019 Jul; 5(7):1235-1240. PubMed ID: 31404214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Features and Application in Asymmetric Catalysis of Chiral Phosphine-Phosphite Ligands.
    Pizzano A
    Chem Rec; 2016 Dec; 16(6):2595-2618. PubMed ID: 27506574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-replication and amplification of enantiomeric excess of chiral multifunctionalized large molecules by asymmetric autocatalysis.
    Kawasaki T; Nakaoda M; Takahashi Y; Kanto Y; Kuruhara N; Hosoi K; Sato I; Matsumoto A; Soai K
    Angew Chem Int Ed Engl; 2014 Oct; 53(42):11199-202. PubMed ID: 25195925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting nanospace for asymmetric catalysis: confinement of immobilized, single-site chiral catalysts enhances enantioselectivity.
    Thomas JM; Raja R
    Acc Chem Res; 2008 Jun; 41(6):708-20. PubMed ID: 18505277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chiral helical oligotriazoles: new class of anion-binding catalysts for the asymmetric dearomatization of electron-deficient N-heteroarenes.
    Zurro M; Asmus S; Beckendorf S; Mück-Lichtenfeld C; Mancheño OG
    J Am Chem Soc; 2014 Oct; 136(40):13999-4002. PubMed ID: 25211494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective transition-metal catalysis via an anion-binding approach.
    Ovian JM; Vojáčková P; Jacobsen EN
    Nature; 2023 Apr; 616(7955):84-89. PubMed ID: 36787801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanostructured catalysts for organic transformations.
    Chng LL; Erathodiyil N; Ying JY
    Acc Chem Res; 2013 Aug; 46(8):1825-37. PubMed ID: 23350747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Step-by-Step Assembly of 2D Confined Chiral Space Endowing Achiral Clusters with Asymmetric Catalytic Activity for Epoxidation of Allylic Alcohols.
    Chang W; Qi B; Song YF
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):36389-36397. PubMed ID: 32666786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chiral N,N'-dioxides: new ligands and organocatalysts for catalytic asymmetric reactions.
    Liu X; Lin L; Feng X
    Acc Chem Res; 2011 Aug; 44(8):574-87. PubMed ID: 21702458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a continuous-flow system for asymmetric hydrogenation using self-supported chiral catalysts.
    Shi L; Wang X; Sandoval CA; Wang Z; Li H; Wu J; Yu L; Ding K
    Chemistry; 2009 Sep; 15(38):9855-67. PubMed ID: 19685536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroformylation and carbonylation processes: new trends in the synthesis of pharmaceuticals.
    Chaudhari RV
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):820-8. PubMed ID: 18946846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond Nature's Chiral Pool: Enantioselective Catalysis in Industry.
    Nugent WA; Rajanbabu TV; Burk MJ
    Science; 1993 Jan; 259(5094):479-83. PubMed ID: 17734166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantiomeric impurities in chiral catalysts, auxiliaries, and synthons used in enantioselective syntheses. Part 5.
    Thakur N; Patil RA; Talebi M; Readel ER; Armstrong DW
    Chirality; 2019 Sep; 31(9):688-699. PubMed ID: 31318099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonlinear Effects in Asymmetric Synthesis and Stereoselective Reactions: Ten Years of Investigation.
    Girard C; Kagan HB
    Angew Chem Int Ed Engl; 1998 Nov; 37(21):2922-2959. PubMed ID: 29711141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.